Delivery Order SPE2DR25D2104-SPE2DR26F3SUS
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections with a ceiling value of $2,214.84. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and carries no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors at a firm fixed price ceiling value of $5,141.53. This is a non-set-aside, competitively awarded contract with an ultimate completion date of November 18, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with a ceiling value of $2,830. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of May 9, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,750.31 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections valued at $20,565.93. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The order is scheduled for completion by May 21, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with a ceiling value of $7,187.24 and ultimate completion date of November 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $4,575.56 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and designates Conshohocken, Pennsylvania as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $4,429.68 to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injections. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of December 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $27,412.46 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,458.20 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injections on December 22, 2025, with completion expected by December 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3SUSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $2,009.12 and an ultimate completion date of January 6, 2026. This is a firm fixed-price delivery order with no set-aside designation, performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion prime vehicle (SPE2DX) that extends through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency and its Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for Zepbound—a GLP-1 receptor agonist used for weight management—reflects AmerisourceBergen's demonstrated capability to fulfill federal pharmaceutical procurement requirements through open competition and its critical role in supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/4/26 |